Active Biotech AB publ
STO:ACTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Other Current Liabilities
Active Biotech AB publ
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Other Current Liabilities
kr185k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-43%
|
|
|
Biogaia AB
STO:BIOG B
|
Other Current Liabilities
kr199.1m
|
CAGR 3-Years
66%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Other Current Liabilities
kr140.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Other Current Liabilities
kr146m
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other Current Liabilities
kr2.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
16%
|
|
|
BioArctic AB
STO:BIOA B
|
Other Current Liabilities
kr505.1m
|
CAGR 3-Years
132%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
See Also
What is Active Biotech AB publ's Other Current Liabilities?
Other Current Liabilities
185k
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Other Current Liabilities amounts to 185k SEK.
What is Active Biotech AB publ's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-43%
Over the last year, the Other Current Liabilities growth was -6%. The average annual Other Current Liabilities growth rates for Active Biotech AB publ have been -8% over the past three years , -54% over the past five years , and -43% over the past ten years .
